PROF

Profound Medical Stock Analysis

AI Rating

Fair
  • Quality2/10
  • Growth↓ 1/10
  • Momentum↑ 7/10
Profound Medical sales and earnings growth
PROF Growth
Low
  • Revenue Y/Y↑ 62.41%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ -49.71%
Profound Medical gross and profit margin trends
PROF Profitability
Neutral
  • Gross margin ↑ 71.80%
  • EPS margin↓ -318.90%
  • ROIC↓ -335.10%
Profound Medical net debt vs free cash flow
PROF Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -153.6

Profound Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗